Olinvacimab (TTAC-0001) is a Human Anti-VEGFR2 mAb for Cancer Research
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody from a fully human naive single-chain variable fragment phage library. Olinvacimab (TTAC-0001) inhibits VEGF and binds to KDR with a Kd…